zolbetuximab
astellas
[]
results from phase 3 spotlight trial for the role for claudin 18.2 with zolbetuximab + folfox for her2 gastric #cancer with pfs and os!! #ascogi23 #ascogi #cancer #cancerresearch #clinicaltrials 
Co-Director/Co-Leader GI Oncology Research; Director, Young Adult Cancers Program; Co-Chair, NCI GI Steering Committee; and Director for Strategic Relations